Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
60S ribosomal protein L27a pseudogene (RPL27AP6)
- Target
- RPL27AP6
- Molecular classification
- Other (Processed pseudogene), Not a receptor, enzyme, transporter, or canonical ribosomal protein
01
Overview
The "60S ribosomal protein L27a pseudogene" (e.g., RPL27AP6) is a processed, non-coding genetic element derived from the RPL27A gene, which encodes a component of the large (60S) ribosome subunit. Ribosomal pseudogenes like this are numerous throughout the genome and typically lack protein-coding ability. They are not considered valid therapeutic targets, as they do not produce functional protein products or serve established pharmacological roles. Some ribosomal pseudogenes have emerging roles as non-coding RNAs, but there is no evidence for such activity in RPL27AP6 specifically[1][4][5][6].
- Other names
- RPL27A_4_770RPL27AP660S ribosomal protein L27a pseudogene 6ENSG00000218426
02
Mechanism of action
None specified, as this pseudogene is not known to be pharmacologically targeted.
03
Biological functions
None established for therapeutic targeting.Some ribosomal pseudogenes may contribute to regulatory RNA or long non-coding RNA pools, but there is no evidence for protein function in this case
04
Disease associations
None directly established.Unlike some ribosomal pseudogenes (e.g., RPL23AP53), no disease association or biomarker utility is described for this specific pseudogene
05
Safety considerations
None. There are no safety concerns or therapeutic challenges documented for this pseudogene.
06
Interacting drugs
None. There are no drugs reported to target ribosomal pseudogenes like RPL27AP6
07
Biomarkers
None. The pseudogene is not used as a biomarker for patient selection or efficacy monitoring
Beyond the preview
Go deeper on 60S ribosomal protein L27a pseudogene (RPL27AP6).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 60S ribosomal protein L27a pseudogene (RPL27AP6).